The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 13, 2018
Filed:
Jul. 15, 2015
Applicant:
The Board of Regents of the University of Texas System, Austin, TX (US);
Inventor:
John E. Wiktorowicz, League City, TX (US);
Assignee:
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEMS, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); G01N 33/564 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6869 (2013.01); G01N 33/564 (2013.01); G01N 33/56983 (2013.01); G01N 33/6851 (2013.01); G01N 2333/185 (2013.01); G01N 2333/47 (2013.01); G01N 2333/4716 (2013.01); G01N 2333/5428 (2013.01); G01N 2333/55 (2013.01); G01N 2333/76 (2013.01); G01N 2800/26 (2013.01);
Abstract
The present invention provides methods for detecting, analyzing, and identifying biomolecules used to identifying patient with dengue-like symptom who are at risk of DHF. The inventive method comprises detecting in a sample from a subject dengue infected patient one or more biomarkers selected from the group consisting of IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, and which are used in a predictive MARS model to detect patients with risk of developing DHF.